Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    ... and will result in prompt and durable hematopoietic engraftment following transplantation into HLA-identical siblings with ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  2. Phase 1 Study of TCP-ATRA for Adult Patients With AML and MDS (TCP-ATRA)

    ... treatment with ATRA and TCP markedly diminished the engraftment of primary human AML cells in murine models, indicating that ...

    Clinical Trial last updated 04/29/2016 - 12:33pm.

  3. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... with malignant and non-malignant disease with successful engraftment and has shown some improvement in GVHD. We do not know if CD34+ ...

    Clinical Trial last updated 04/28/2016 - 8:36am.

  4. Telomere Length and Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

    ... between donor telomere length and bone marrow engraftment or incidence of graft-versus-host disease (GVHD) .   ... influence the HSCT outcome is still lacking. Bone marrow engraftment failure and GVHD incidence are major factors that impact HSCT ...

    Research Review last updated 05/02/2016 - 9:13am.

  5. Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

    ... -based conditioning regimens provide stable engraftment and may avoid the toxicities seen after HCT for DC, but studies ...

    Clinical Trial last updated 04/27/2016 - 8:49am.

  6. Safety Study of Cord Blood Units for Stem Cell Transplants

    ... rejection Assess incidence of neutrophil engraftment > 500 /ul Determine 1 year survival after cord blood ... incidence of chronic GVHD Determine platelet engraftment of > 20,000/ul and > 50,000/ul Determine CBU-derived ...

    Clinical Trial last updated 04/27/2016 - 2:25pm.

  7. Bone Marrow and Stem Cell Transplantation

    ... blood cells your body needs. This process is called engraftment and may take two to three or even four weeks. Until the donor ... transplant, and there may also be higher risks of non-engraftment and recurrence of the disease being treated. This type ... of immune suppression prior to HSCT in order to alow for engraftment of donor stem cells.  Initially only high dose of chemo or ...

    Page last updated 09/30/2014 - 11:47am.

  8. New York Blood Center National Cord Blood Program

    ... endpoints, primarily myeloid and platelet engraftment , transplant related mortality, overall survival, acute and ...

    Clinical Trial last updated 04/27/2016 - 3:36pm.

  9. Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerou

    ... then if there is no evidence of active GVHD and donor engraftment is > 95% (or by Principal Investigator [PI] approval) taper ...

    Clinical Trial last updated 04/26/2016 - 2:09pm.

  10. Clinical Trials Report for June 2015

    ... intensity conditioning regimen to allow successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from ...

    Page last updated 06/18/2015 - 11:47am.